Skin Lymphoma The Illustrated Guide, Fifth Edition
Half Title
Title Page
Copyright
Dedication
Contents
List of teaching cases
Preface
Acknowledgments
Chapter 1 Introduction
Classification of cutaneous lymphomas
Examination of patients
Staging investigations
Surgical techniques
Histopathology, immunophenotype, and molecular genetics
Other methods used in the study of cutaneous lymphoid infiltrates
Other genetic investigations
Lymphoma microenvironment and lymphoma‐associated microorganisms
Pseudomalignancy, premalignancy, and early malignancy
References
Chapter 2 The “parapsoriases”: a riddle, wrapped in a mystery, inside an enigma
References
Chapter 3 Mycosis fungoides
Onset of mycosis fungoides or exacerbation of undiagnosed disease under treatment with immunomodulatory agents
Clinical features
Extracutaneous involvement
Association with other diseases
Histopathology, immunophenotype, and molecular genetics
Histopathologic differential diagnosis from inflammatory conditions
Clinical and histopathologic variants
Prognosis
References
Chapter 4 Seary syndrome
Onset/progression under systemic therapies for benign inflammatory dermatoses
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
References
Chapter 5 Primary cutaneous CD30+ lymphoproliferative disorders
Clinical features
Histopathology, immunophenotype, and molecular genetics
Clinicopathologic differential diagnosis
Treatment
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
References
Chapter 6 Subcutaneous panniculitis‐like T‐cell lymphoma
Clinical features
Histopathology, immunophenotype, and molecular genetics
Differential diagnosis with other cutaneous NK/T‐cell lymphomas with prominent involvement of the subcutaneous tissue
Differential diagnosis with lupus panniculitis
Treatment
Prognosis
References
Chapter 7 Aggressive cutaneous cytotoxic lymphomas
Clinical features
Histopathology, immunophenotype, and molecular genetics
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
References
Chapter 8 Cutaneous peripheral T‐cell lymphoma, not otherwise specified (NOS)
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
References
Chapter 9 Cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
Final considerations
References
Chapter 10 Acral CD8+ cutaneous T‐cell lymphoma
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
References
Chapter 11 Cutaneous adult T‐cell leukemia/lymphoma
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
References
Chapter 12 Other cutaneous NK/T‐cell lymphomas
Clinical features, histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features, histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
References
Chapter 13 Cutaneous follicle center lymphoma
Clinical features
Histopathology, immunophenotype, and molecular genetics
Differential diagnosis of cutaneous follicle center lymphoma, diffuse type, from cutaneous diffuse large B‐cell lymphoma, leg t
Treatment
Prognosis
References
Chapter 14 Cutaneous marginal zone lymphoma (cutaneous MALT lymphoma) and variants
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
References
Chapter 15 Cutaneous diffuse large B‐cell lymphoma, leg type
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment
Prognosis
References
Chapter 16 Intravascular large cell lymphomas
Clinical features
Histopathology, immunophenotype, and molecular genetics
Intravascular large B‐cell lymphoma colonizing hemangiomas
Treatment and prognosis
References
Chapter 17 Other cutaneous B‐cell lymphomas
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
References
Chapter 18 Cutaneous lymphomas in immunosuppressed individuals
CUTANEOUS POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
CUTANEOUS LYMPHOMAS IN HIV‐INFECTED INDIVIDUALS
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS IN OTHER IATROGENIC AND NON‐IATROGENIC IMMUNE DEFICIENCIES
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
References
Chapter 19 Cutaneous manifestations of B‐cell chronic lymphocytic leukemia
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
PROGRESSION TO DIFFUSE LARGE B‐CELL LYMPHOMA (RICHTER SYNDROME)
References
Chapter 20 Cutaneous manifestations of myelogenous leukemia
Clinical features
Histopathology, immunophenotype, and molecular genetics
Immunophenotype
Treatment and prognosis
References
Chapter 21 Blastic plasmacytoid dendritic cell neoplasm
Clinical features
Histopathology, immunophenotype, and molecular genetics
Immunophenotype
Treatment
Prognosis
MATURE PLASMACYTOID DENDRITIC CELL PROLIFERATIONS ASSOCIATED WITH MYELOID NEOPLASMS
References
Chapter 22 Cutaneous manifestations of other leukemias
SPECIFIC SKIN MANIFESTATIONS OF OTHER TYPES OF LEUKEMIA
References
Chapter 23 Cutaneous lymphoblastic lymphomas
CUTANEOUS B‐LYMPHOBLASTIC LYMPHOMA
Clinical features
Histopathology, immunophenotype, and molecular genetics
Differential diagnosis
Treatment and prognosis
CUTANEOUS T‐LYMPHOBLASTIC LYMPHOMA
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
References
Chapter 24 Cutaneous manifestations of Hodgkin lymphoma
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
References
Chapter 25 Cutaneous composite lymphomas
Clinical features
Histopathology, immunophenotype, and molecular genetics
Treatment and prognosis
References
Chapter 26 Nonneoplastic cutaneous signs of systemic lymphomas
References
Chapter 27 Cutaneous lymphomas in children and adolescents
References
Chapter 28 Pseudolymphomas of the skin
Lupus tumidus and lymphocytic infiltration of the skin (Jessner–Kanof)
Lupus panniculitis
Other pseudolymphomas associated with cutaneous lupus erythematosus
References
Chapter 29 The cutaneous “atypical lymphoid proliferation”
References
Index